AST-120 Treatment Alters the Gut Microbiota Composition and Suppresses Hepatic Triglyceride Levels in Obese Mice
- 1 June 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Endocrine Research
- Vol. 46 (4), 178-185
- https://doi.org/10.1080/07435800.2021.1927074
Abstract
Background: The prevalence of nonalcoholic fatty liver disease (NAFLD) has been increasing worldwide. The existence of a relationship between the microbiota and the pathology of hepatic steatosis is also becoming increasingly clear. AST-120, an oral spherical carbon adsorbent, has been shown to be useful for delaying dialysis initiation and improving uremic symptoms in patients with chronic kidney disease. However, little is known about the effect of AST-120 on fatty liver. Methods: AST-120 (5% w/w) was administrated to 6-week-old male db/db mice for 8 weeks. The body weight, blood glucose and food consumption were examined. Hepatic triglyceride (TG) levels, lipid droplets and epididymal fat cell size were measured. The gut microbiota compositions were investigated in feces and cecum. Results: Significant decreases of the hepatic weight and hepatic TG levels were observed in the AST-120-treated db/db mice. Furthermore, AST-120 treatment was also associated with a decrease of Bacteroidetes, increase of Firmicutes, and a reduced ratio of Bacteroidetes to Firmicutes (B/F ratio) in the feces in the db/db mice. The B/F ratio in the feces was correlated with the liver weight and area of the liver occupied by lipid droplets in the db/db mice. Conclusions: These data suggest that AST-120 treatment alters the composition of the fecal microbiota and suppresses hepatic TG levels in the db/db mice.Keywords
This publication has 32 references indexed in Scilit:
- The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanismsBioscience of Microbiota, Food and Health, 2019
- The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in ThaisBioMed Research International, 2018
- Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitisBMC Gastroenterology, 2017
- Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent modelThe Esophagus, 2017
- Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver DiseaseScientific Reports, 2016
- AST-120 for the management of progression of chronic kidney diseaseInternational Journal of Nephrology and Renovascular Disease, 2014
- Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2013
- Bacterial Community Variation in Human Body Habitats Across Space and TimeScience, 2009
- Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled TrialAmerican Journal of Kidney Diseases, 2009
- Oral Sorbent Suppresses Accumulation of Albumin-Bound Indoxyl Sulphate in Serum of Haemodialysis PatientsNephrology Dialysis Transplantation, 1991